Video

Dr. Heifetz Discusses Rural Oncology Care

Laurence J. Heifetz, MD, medical director, Gene Upshaw Memorial Tahoe Forest Cancer Center, discusses rural oncology care.

Laurence J. Heifetz, MD, medical director, Gene Upshaw Memorial Tahoe Forest Cancer Center, discusses rural oncology care.

About 20% of the US population lives in rural areas, Heifetz says. This means that those people have less access to state-of-the-art medical care, particularly cancer care, which is expensive and difficult. Heifetz says that when a patient is living far away from a thought center, which are in most major cities across the country, they will not get care as quickly as a patient who lives within the city limits.

At the Tahoe Forest Cancer Center, a system has been put in place to address the needs of the 4 largest cancers that make up 80% of diagnoses—gastrointestinal, genitourinary, lung, and breast cancer. Heifetz says that this remote facility has partnered up with the UC Davis Comprehensive Cancer Center, and is now a part of the UC Davis Comprehensive Cancer Care Network, which is comprised of 4 rural cancer centers.

Related Videos
Jennifer Scalici, MD
Steven H. Lin, MD, PhD
Anna Weiss, MD, associate professor, Department of Surgery, Oncology, associate professor, Cancer Center, University of Rochester Medicine
Roy S. Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology), professor, pharmacology, deputy director, Yale Cancer Center; chief, Hematology/Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital; assistant dean, Translational Research, Yale School of Medicine
Victor Moreno, MD, PhD
Tiago Biachi, MD, PhD
Dr Girard on De Novo and Acquired Resistance Alterations in HER2-Altered NSCLC
Haley M. Hill, PA-C, discusses the role of multidisciplinary management in NRG1-positive non–small cell lung cancer and pancreatic cancer.
Haley M. Hill, PA-C, discusses preliminary data for zenocutuzumab in NRG1 fusion–positive non–small cell lung cancer and pancreatic cancer.
Haley M. Hill, PA-C, discusses how physician assistants aid in treatment planning for NRG1-positive non–small cell lung cancer and pancreatic cancer.